SlideShare ist ein Scribd-Unternehmen logo
1 von 83
Downloaden Sie, um offline zu lesen
• Introduction of Phage Display Technology
• General view to biology of filamentous phages
• Biology of Phagemids
• Types of host & process of infection
• Display of antibody fragments
• Types of phage display systems
• Phage-display cycle(Biopanning & Screening)
• Phage display libraries
• Application of phage display
Phage display orginal
 Filamentous phages are group of non-lytic
phages that
 incorporate round single stranded DNA. The
family of Ff, M13,
 fd, and f1 are vital phages which have utility
in phage display
 which among them M13 phage is the most
generally used.
 M13 phage, is a bacteriophage that is (6–7) nm in diameter
and 900 nm long and is a member of F positive family. The
genome of M13 phage is 6407 bp long that encodes three
groups of phage proteins:
 1 –proteins involving in replication (pII, pX and pV),
 2 –morphogenetic (pI and pIV), and
 3 – structural (pVIII, pIII,pVI, pVII and pIX). The coating
proteins of phage categorized into major (pVIII) and minor
(PIII and pVI) proteins.
 Each phage has about 2700 copies of pVIII. The N-terminal
region of pIII plays important role in binding of phage to
the F-pilus of the bacterium [13–15].
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
 Phagemids are Ff-phage-derived vectors, containing the
replication origin of a plasmid. The basic components of a
phagemid mainly include the replication origin of a
plasmid, the selective marker, the intergenic region (IG
region, usually contains the packing sequence and
replication origin of minus and plus strands), a gene of a
phage coat protein, restriction enzyme recognition sites, a
promoter and a DNA segment encoding a signal peptide .
Additionally, a molecular tag can be included to facilitate
screening of phagemid-based library. The functions of
these elements will be discussed in Construction
Strategies and Characteristics of Phagemids in
detail.Phagemids can be converted to filamentous phage
particles with the same morphology as Ff phage22 by co-
infection with the helper phages,23such as
R408,24M13KO725and VCSM13.
Phage display orginal
Phage display orginal
Phagemids combine features of plasmids
(i.e., carry antibiotic resistance and
enable replication of dsDNA)
with features of phage vectors
(i.e., allow for production and
packing of ssDNA into virions).
 Phagemids are engineered to express recombinant
p3 fusions under controlled conditions, but do not
encode any viral structural or replication proteins.
 Only upon superinfection of a bacterial host by a
helper phage which contributes the missing genes
can the phagemid ssDNA replication and packing
take place.
 Helper phage are defective in their origin of
replication or packaging signal thereby ensuring
preferential packing of phagemids.
 The amber codon TAG can be inserted between
foreign genes and coat protein genes .
 host strains 1: in E. coli supE strains such as XL-1 Blue
MRFV, TG1, DH5aFV, ER2738, ER2537 and 16C9, TAG codon is
recognized as glutamic acid codon instead of stop codon. As a
result, the foreign protein is expressed as a fusion protein
presented on the surface of progeny phages.
2 : In the non-suppressor strains such as TOP10F', JS5
and HB2151, TAG is recognized as stop codon that
terminates translation at C-terminus of foreign
proteins and allows expression of the foreign pro-
teins in a soluble form.
 First, the phagemid particles containing the
DNA fragment encoding a foreign protein
infect theF^strain of Escherichia coli. Upon
entering the host cell, the single-stranded
DNA (ssDNA) of phagemid particles can be
converted into replicative form (RF) of the
phagemids by the host RNA and DNA
polymerases and topoisomerase, which act
on the replication origin of minus strand
located in the IG region of the phagemids.
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Types of phage display systems
 In a “type 3” vector, there is a single phage chromosome
(genome) bearing a single gene III which accepts foreign DNA
inserts andencodes a single type of pIII molecule. The foreign
peptide encoded by the insert is theoretically displayed on all
five pIII molecules on a virion (though in practice normal
proteolytic enzymes in the host bacterium often remove the
foreign peptide from some or even most copies of pIII, especially
if the foreign peptide is large). Similarly, type 8 . In a type 88
vector, the phage genome bears two genes VIII, encoding two
different types of pVIII molecule; one is ordinarily recombinant
(i.e., bears a foreign DNA insert) and the other wild-type. The
resulting virion is a mosaic, its coat comprised of both wild-type
and recombinant pVIII molecules (the former usually
predominating). This allows hybrid pVIII proteins with quite large
foreign peptides to be displayed on the virion surface, even
though the hybrid protein by itself cannot support phage
assembly. Similarly, a type 33 vector bears two genes III, one of
which is recombinant.
 A type 8+8 system differs from a type 88 system in that the two genes VIII
are on separate genomes. The wild-type version is on a phage (usually called
the “helper” phage), while the recombinant version is on a special kind of
plasmid called a “phagemid. Like other plasmids used in recombinant DNA
research, a phagemid carries a plasmid replication origin that allows it to
replicate normally in an E. coli host and an antibiotic resistance gene that
allows plasmid-bearing host cells to be selected. But it also carries a
filamentous phage replication origin, which is inactive until the cell is
infected with the helper phage. Then the phage replication protein acts not
only on the phage origin on the helper phage DNA but also on the phage
origin on the phagemid DNA. Two types of progeny virions are thus secreted:
particles carrying helper phage DNA and particles carrying phagemid DNA.
Both these virions, like the type 88 virions, are mosaics, whose coats are
composed of a mixture of recombinant and wild-type pVIII molecules. When
a phagemid virion infects a cell, the cell acquires the antibiotic resistance
carried by the phagemid. When a helper phage virion infects a cell, the cell
goes on to produce progeny helper virions in the normal way; the progeny
virions, unlike the original infecting virion, are not mosaic, since the helper
carries only a single gene VIII. Type 3+3 and 6+6 systems are like type 8+8
systems, except that the phagemid carries an insert-bearing recombinant
gene III or VI, respectively, rather than VIII. The recombinant pIII encoded by
a type 3+3 phagemid is usually missing the N-terminal domain, since cells
expressing this domain are resistant to superinfection by helper phage.
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
 Fab
 F(ab)2
 Fv
 ScFv
 HcAb
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
 Library A population of clones with each
clone containing one random piece of
chromsomal DNA cloned into a vector.
Phage display orginal
 Production of gene fragment: This phase involves
animal immunization with the desired antigen
and then isolation of B lymphocytes, mRNA
extraction and cDNA synthesis. The synthesized
cDNA contain genetic information of all
antibodies targeting various antigens and consist
of approximately10 ^9to10^ 11 lymphocyte
clones.Cloning of gene fragments in the
phagemid vectors: Genes related to the different
clones of antibodies are digested with restriction
enzymes, clone into phagemid vectors and then
display on the surface of phages.
 So far, a variety of phages like phages l, T4,
T7and M13 have been described for
displaying of antibody fragments. These
vectors help to the displayed antibodies to
maintain their function at the surface of
phage. But using of phages like M13 that not
destroy the bacterial cells is most
applicable.The phagemid vectors need helper
phage to package and exit from the bacterial
cells and enter to the medium.
 Selection of specific phages: After cloning of the
fragments into phagemid vectors, because of
diversity in antibody gene,variety of clones of
antibodies display on the surface of the phage.
Selections of specific clone that recognize the
antigen(target of interest) perform by
biopanning. Since the antibody fragments on the
surface of the phage are functional so the phage
carrying specific antibody can be isolated from
non-specific phages (due to antigen–antibody
binding properties).
 The panning process include: immobilization
of antigen, binding of the phages, washing
and removing non- bonded phages, elution
of the bonded phages, re-infection of the
bacterial cells to amplify the eluted phages,
purification of the recombinant phages and
re-expression of antibodies on the surface of
phage. Biopanning usually repeat 3 to 5 times
to isolate specific antibodies with high affinity
to target.
 Screening: Isolation of antibodies with high
affinity to target is the main aim of this step.
Screening is performed using different methods
like: immunoassay, immunocytochemistry,active
isolation of cells due to their fluorescent
properties and immunoblotting. In immunoassay,
at first antigen is coated on solid phase, phage
displaying antibody is added and then secondary
antibody that detect the surface proteins of
phages is added. After incubation and washing
the signal value and binding is measured in
appropriate wave length.
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Screening key act
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
Phage display orginal
 Production of mAbs by phage display:
Hybridoma and phage display technology are
common techniques to obtain monoclonal
antibodies.Combination of B cell producing
monoclonal antibody with mouse myeloma
cells is the basis of hybridoma technology.
 Despite of advantage of hybridoma
technology there are some limitation: poor
immunogenicity of some targets, high
production cost,, time-consuming and need
to myeloma cells.
 Phage display has been used in enzymology to determine the
substrate specificity and to develop modulators of both the
active and
allostericsitesoftheenzyme(Diamond,2007;KehoeandKay,2005
;Kayetal.,2001;Benhar,2001).Themethodcanbeusedtodisplaym
utantsof 854J. Pande et al. / Biotechnology Advances 28
(2010) 849–858 enzymes to study their mechanisms of action
(Vanwetswinkel et al.,2000; Ponsard et al., 2001; Verhaert et
al., 2002). Since filamentous phage is resistant to broad
range of proteases, it has been used in identification of
substrates of various proteases (Matthews and
Wells,1993;Diamond,2007).
 Phage display is a powerful technique in isolation of
monoclonal antibodies with high affinity to their target.
 Epitope mapping and finding mimotopes
 Another application of phage display is to map epitope or
binding site of antigen that is involved in interaction with
anti body .Peptide phage display libraries described in
above are useful tools for identification of continuous or
linear epitopes involve in interaction with antibody.
Isolation and identification of mimotopes from peptide
phage libraries is powerful approach to improve
immunological studies in order to design and develop
vaccine candidate.Through peptide phage library and
biopanning process, phages carrying peptides mimic the
epitopes of the antigen are identified. Length of epitopes
that are recognized by antibodies is between four to six
amino acids. So, heptapeptide libraries are appropriate for
identification of all linear epitopes.
 Phage display has been used to identify agonists and antagonists to
probe the receptor structure and function. The peptide libraries can be
screened for binding to functionally folded extracellular domains of
receptors that contain the site for natural ligand. Selected peptides that
recognize the binding interface of the receptor can antagonize its
interaction with the natural ligand. The structural and functiona
properties of individual members of a large receptor family that bind the
same natural ligands can be characterized with affinity selected peptides
specific for each member (Koolpe et al., 2005). Phage encoded peptide
ligands have also been selected for targets like G-protein coupled
receptors, in which it is difficult to purify the
functionallyfoldedextracellular receptor domains. Antibodiesspecific for
the known receptor ligand can be used as a target to affinity select
mimotopes of the ligand from phage display library. The selected
mimotopes can be used to study the mechanism of interaction of ligand
with its receptor and allow the development of potent agonist and
antagonists (Bonetto et al., 2005). Receptor antagonists can also be
obtainedby selecting peptides thatbindtothereceptoragonistand thereby
inhibit its interaction with the receptor. An example is the invention of
antagonistic peptide binding insulin-like growth factor-1(IGF-1)
(Deshayes et al., 2002)
Phage display orginal
Phage display orginal
Phage display orginal

Más contenido relacionado

Was ist angesagt?

Yeast two hybrid
Yeast two hybridYeast two hybrid
Yeast two hybridhina ojha
 
Next generation sequencing
Next generation sequencingNext generation sequencing
Next generation sequencingSwathi Prabakar
 
shotgun sequncing
 shotgun sequncing shotgun sequncing
shotgun sequncingSAIFALI444
 
Protein dna interactions
Protein dna interactionsProtein dna interactions
Protein dna interactionsMandeep Kaur
 
SAGE (Serial analysis of Gene Expression)
SAGE (Serial analysis of Gene Expression)SAGE (Serial analysis of Gene Expression)
SAGE (Serial analysis of Gene Expression)talhakhat
 
Yeast two hybrid system
Yeast two hybrid systemYeast two hybrid system
Yeast two hybrid systemiqraakbar8
 
Linker, Adaptor, Homopolymeric Tailing & Terminal Transferase
Linker, Adaptor, Homopolymeric Tailing & Terminal TransferaseLinker, Adaptor, Homopolymeric Tailing & Terminal Transferase
Linker, Adaptor, Homopolymeric Tailing & Terminal TransferaseUtsa Roy
 
lambda cloning vector
lambda cloning vectorlambda cloning vector
lambda cloning vectorNOMI KhanS
 
Lectut btn-202-ppt-l33. site-directed mutagenesis
Lectut btn-202-ppt-l33. site-directed mutagenesisLectut btn-202-ppt-l33. site-directed mutagenesis
Lectut btn-202-ppt-l33. site-directed mutagenesisRishabh Jain
 
Colony hybridisation
Colony hybridisation Colony hybridisation
Colony hybridisation Manimaran G
 

Was ist angesagt? (20)

Yeast hybrid system
Yeast hybrid systemYeast hybrid system
Yeast hybrid system
 
transposon mediated mutagenesis
transposon mediated mutagenesistransposon mediated mutagenesis
transposon mediated mutagenesis
 
Yeast two hybrid
Yeast two hybridYeast two hybrid
Yeast two hybrid
 
P bluescript
P bluescriptP bluescript
P bluescript
 
pET vectors
pET vectorspET vectors
pET vectors
 
Yeast n hybrid
Yeast n hybridYeast n hybrid
Yeast n hybrid
 
pUC18 vector
pUC18 vector pUC18 vector
pUC18 vector
 
Next generation sequencing
Next generation sequencingNext generation sequencing
Next generation sequencing
 
shotgun sequncing
 shotgun sequncing shotgun sequncing
shotgun sequncing
 
S1 Mapping
S1 Mapping  S1 Mapping
S1 Mapping
 
Protein dna interactions
Protein dna interactionsProtein dna interactions
Protein dna interactions
 
SAGE (Serial analysis of Gene Expression)
SAGE (Serial analysis of Gene Expression)SAGE (Serial analysis of Gene Expression)
SAGE (Serial analysis of Gene Expression)
 
Yeast two hybrid system
Yeast two hybrid systemYeast two hybrid system
Yeast two hybrid system
 
Linker, Adaptor, Homopolymeric Tailing & Terminal Transferase
Linker, Adaptor, Homopolymeric Tailing & Terminal TransferaseLinker, Adaptor, Homopolymeric Tailing & Terminal Transferase
Linker, Adaptor, Homopolymeric Tailing & Terminal Transferase
 
lambda cloning vector
lambda cloning vectorlambda cloning vector
lambda cloning vector
 
Lectut btn-202-ppt-l33. site-directed mutagenesis
Lectut btn-202-ppt-l33. site-directed mutagenesisLectut btn-202-ppt-l33. site-directed mutagenesis
Lectut btn-202-ppt-l33. site-directed mutagenesis
 
Phagemid vector
Phagemid vectorPhagemid vector
Phagemid vector
 
Genomic library
Genomic libraryGenomic library
Genomic library
 
Bacteriophage vectors
Bacteriophage vectorsBacteriophage vectors
Bacteriophage vectors
 
Colony hybridisation
Colony hybridisation Colony hybridisation
Colony hybridisation
 

Ähnlich wie Phage display orginal

Host cell and vectors
Host cell and vectorsHost cell and vectors
Host cell and vectorsDr. R Salini
 
08 Kjm206 Expression Vector, Plasmid Vector
08 Kjm206 Expression Vector, Plasmid Vector08 Kjm206 Expression Vector, Plasmid Vector
08 Kjm206 Expression Vector, Plasmid VectorJeneesh Jose
 
PLASMIDS AND VECTORS
PLASMIDS AND VECTORSPLASMIDS AND VECTORS
PLASMIDS AND VECTORSVidyashrish
 
A comprehensive study of shuttle vector & binary vector and its rules of in ...
A comprehensive study of shuttle vector & binary vector and its rules of in  ...A comprehensive study of shuttle vector & binary vector and its rules of in  ...
A comprehensive study of shuttle vector & binary vector and its rules of in ...PRABAL SINGH
 
CONFERENCE 5-Techniques in Genetic Engineering.ppt
CONFERENCE 5-Techniques in Genetic Engineering.pptCONFERENCE 5-Techniques in Genetic Engineering.ppt
CONFERENCE 5-Techniques in Genetic Engineering.pptDicksonDaniel7
 
2. VECTORS ppt.pdf
2. VECTORS ppt.pdf2. VECTORS ppt.pdf
2. VECTORS ppt.pdfamanuelzeru
 
Plasmids and bacteriophages
Plasmids and bacteriophagesPlasmids and bacteriophages
Plasmids and bacteriophagesdrsoniabansal
 
DESIGN OF PLASMID VECTOR & PROKARYOTIC AND EUKARYOTIC VECTORS
DESIGN OF PLASMID VECTOR & PROKARYOTIC AND EUKARYOTIC VECTORSDESIGN OF PLASMID VECTOR & PROKARYOTIC AND EUKARYOTIC VECTORS
DESIGN OF PLASMID VECTOR & PROKARYOTIC AND EUKARYOTIC VECTORSANAND AGRICULTURAL UNIVERSITY
 
ADVANCES IN MOLECULAR PATHOGENESIS (2).pptx
ADVANCES IN MOLECULAR PATHOGENESIS (2).pptxADVANCES IN MOLECULAR PATHOGENESIS (2).pptx
ADVANCES IN MOLECULAR PATHOGENESIS (2).pptxJenniferSZiegen
 
CLONING VECTORS SMG
CLONING VECTORS  SMGCLONING VECTORS  SMG
CLONING VECTORS SMGsajigeorge64
 
MSc mic gen plasmids bacteriophages
MSc mic gen plasmids bacteriophagesMSc mic gen plasmids bacteriophages
MSc mic gen plasmids bacteriophagesChitrarpitaDas2
 
Synthesis of c dna
Synthesis of c dnaSynthesis of c dna
Synthesis of c dnaDUVASU
 

Ähnlich wie Phage display orginal (20)

Host cell and vectors
Host cell and vectorsHost cell and vectors
Host cell and vectors
 
Plasmids
PlasmidsPlasmids
Plasmids
 
Vectors.pptx
 Vectors.pptx Vectors.pptx
Vectors.pptx
 
08 Kjm206 Expression Vector, Plasmid Vector
08 Kjm206 Expression Vector, Plasmid Vector08 Kjm206 Expression Vector, Plasmid Vector
08 Kjm206 Expression Vector, Plasmid Vector
 
PLASMIDS AND VECTORS
PLASMIDS AND VECTORSPLASMIDS AND VECTORS
PLASMIDS AND VECTORS
 
A comprehensive study of shuttle vector & binary vector and its rules of in ...
A comprehensive study of shuttle vector & binary vector and its rules of in  ...A comprehensive study of shuttle vector & binary vector and its rules of in  ...
A comprehensive study of shuttle vector & binary vector and its rules of in ...
 
299860 633981096231012500
299860 633981096231012500299860 633981096231012500
299860 633981096231012500
 
CONFERENCE 5-Techniques in Genetic Engineering.ppt
CONFERENCE 5-Techniques in Genetic Engineering.pptCONFERENCE 5-Techniques in Genetic Engineering.ppt
CONFERENCE 5-Techniques in Genetic Engineering.ppt
 
Vectors
VectorsVectors
Vectors
 
2. VECTORS ppt.pdf
2. VECTORS ppt.pdf2. VECTORS ppt.pdf
2. VECTORS ppt.pdf
 
Animal viral vector
Animal viral vector Animal viral vector
Animal viral vector
 
Plasmids as vectors
Plasmids as vectorsPlasmids as vectors
Plasmids as vectors
 
Plasmids and bacteriophages
Plasmids and bacteriophagesPlasmids and bacteriophages
Plasmids and bacteriophages
 
Cloning vector
Cloning vectorCloning vector
Cloning vector
 
DESIGN OF PLASMID VECTOR & PROKARYOTIC AND EUKARYOTIC VECTORS
DESIGN OF PLASMID VECTOR & PROKARYOTIC AND EUKARYOTIC VECTORSDESIGN OF PLASMID VECTOR & PROKARYOTIC AND EUKARYOTIC VECTORS
DESIGN OF PLASMID VECTOR & PROKARYOTIC AND EUKARYOTIC VECTORS
 
PLASMID AND ITS TYPES.pptx
PLASMID AND ITS TYPES.pptxPLASMID AND ITS TYPES.pptx
PLASMID AND ITS TYPES.pptx
 
ADVANCES IN MOLECULAR PATHOGENESIS (2).pptx
ADVANCES IN MOLECULAR PATHOGENESIS (2).pptxADVANCES IN MOLECULAR PATHOGENESIS (2).pptx
ADVANCES IN MOLECULAR PATHOGENESIS (2).pptx
 
CLONING VECTORS SMG
CLONING VECTORS  SMGCLONING VECTORS  SMG
CLONING VECTORS SMG
 
MSc mic gen plasmids bacteriophages
MSc mic gen plasmids bacteriophagesMSc mic gen plasmids bacteriophages
MSc mic gen plasmids bacteriophages
 
Synthesis of c dna
Synthesis of c dnaSynthesis of c dna
Synthesis of c dna
 

Último

TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUTARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUKanhu Charan
 
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptxANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptxsiddharthroy26587
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, PDr.Shalu Jain
 
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTIONANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTIONojaswinihemane
 
Substance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionSubstance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionZeinabEmad3
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptKavitha Krishnan
 
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY  pptxHERPES SIMPLEX VIRUS 12032019 TUESDAY  pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptxPulkitMittal54
 
SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN              .pdfSGK VIÊM KHỚP DẠNG THẤP YHN              .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN .pdfHongBiThi1
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...Genesis Institute of Pharmacy, Radhanagari.
 
Problems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfProblems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfNetHelix
 
airway management recorded for S2.pptx
airway management  recorded  for S2.pptxairway management  recorded  for S2.pptx
airway management recorded for S2.pptxnakera38
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUKanhu Charan
 
Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)pranavguleria2
 
Explaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyExplaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyYves Sucaet
 
Reproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxReproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxVeereshDemashetti
 
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxThyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxRajendra Dev Bhatt
 
Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Ahmad Thanin
 
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on timeTracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on timeQuick MedTalk
 
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
SGK PHÙ PHỔI CẤP ĐHYHN                   .pdfSGK PHÙ PHỔI CẤP ĐHYHN                   .pdf
SGK PHÙ PHỔI CẤP ĐHYHN .pdfHongBiThi1
 

Último (20)

TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUTARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
 
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptxANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, P
 
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTIONANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
 
Substance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionSubstance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), Addiction
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
 
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY  pptxHERPES SIMPLEX VIRUS 12032019 TUESDAY  pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
 
SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN              .pdfSGK VIÊM KHỚP DẠNG THẤP YHN              .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
 
Problems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfProblems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdf
 
airway management recorded for S2.pptx
airway management  recorded  for S2.pptxairway management  recorded  for S2.pptx
airway management recorded for S2.pptx
 
Oral disorders .pptx
Oral disorders .pptxOral disorders .pptx
Oral disorders .pptx
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
 
Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)
 
Explaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyExplaining "pathology" in digital pathology
Explaining "pathology" in digital pathology
 
Reproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxReproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptx
 
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxThyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
 
Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)
 
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on timeTracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on time
 
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
SGK PHÙ PHỔI CẤP ĐHYHN                   .pdfSGK PHÙ PHỔI CẤP ĐHYHN                   .pdf
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
 

Phage display orginal

  • 1. • Introduction of Phage Display Technology • General view to biology of filamentous phages • Biology of Phagemids • Types of host & process of infection • Display of antibody fragments • Types of phage display systems • Phage-display cycle(Biopanning & Screening) • Phage display libraries • Application of phage display
  • 3.  Filamentous phages are group of non-lytic phages that  incorporate round single stranded DNA. The family of Ff, M13,  fd, and f1 are vital phages which have utility in phage display  which among them M13 phage is the most generally used.
  • 4.  M13 phage, is a bacteriophage that is (6–7) nm in diameter and 900 nm long and is a member of F positive family. The genome of M13 phage is 6407 bp long that encodes three groups of phage proteins:  1 –proteins involving in replication (pII, pX and pV),  2 –morphogenetic (pI and pIV), and  3 – structural (pVIII, pIII,pVI, pVII and pIX). The coating proteins of phage categorized into major (pVIII) and minor (PIII and pVI) proteins.  Each phage has about 2700 copies of pVIII. The N-terminal region of pIII plays important role in binding of phage to the F-pilus of the bacterium [13–15].
  • 12.  Phagemids are Ff-phage-derived vectors, containing the replication origin of a plasmid. The basic components of a phagemid mainly include the replication origin of a plasmid, the selective marker, the intergenic region (IG region, usually contains the packing sequence and replication origin of minus and plus strands), a gene of a phage coat protein, restriction enzyme recognition sites, a promoter and a DNA segment encoding a signal peptide . Additionally, a molecular tag can be included to facilitate screening of phagemid-based library. The functions of these elements will be discussed in Construction Strategies and Characteristics of Phagemids in detail.Phagemids can be converted to filamentous phage particles with the same morphology as Ff phage22 by co- infection with the helper phages,23such as R408,24M13KO725and VCSM13.
  • 15. Phagemids combine features of plasmids (i.e., carry antibiotic resistance and enable replication of dsDNA) with features of phage vectors (i.e., allow for production and packing of ssDNA into virions).
  • 16.  Phagemids are engineered to express recombinant p3 fusions under controlled conditions, but do not encode any viral structural or replication proteins.  Only upon superinfection of a bacterial host by a helper phage which contributes the missing genes can the phagemid ssDNA replication and packing take place.  Helper phage are defective in their origin of replication or packaging signal thereby ensuring preferential packing of phagemids.
  • 17.  The amber codon TAG can be inserted between foreign genes and coat protein genes .  host strains 1: in E. coli supE strains such as XL-1 Blue MRFV, TG1, DH5aFV, ER2738, ER2537 and 16C9, TAG codon is recognized as glutamic acid codon instead of stop codon. As a result, the foreign protein is expressed as a fusion protein presented on the surface of progeny phages. 2 : In the non-suppressor strains such as TOP10F', JS5 and HB2151, TAG is recognized as stop codon that terminates translation at C-terminus of foreign proteins and allows expression of the foreign pro- teins in a soluble form.
  • 18.  First, the phagemid particles containing the DNA fragment encoding a foreign protein infect theF^strain of Escherichia coli. Upon entering the host cell, the single-stranded DNA (ssDNA) of phagemid particles can be converted into replicative form (RF) of the phagemids by the host RNA and DNA polymerases and topoisomerase, which act on the replication origin of minus strand located in the IG region of the phagemids.
  • 29. Types of phage display systems
  • 30.  In a “type 3” vector, there is a single phage chromosome (genome) bearing a single gene III which accepts foreign DNA inserts andencodes a single type of pIII molecule. The foreign peptide encoded by the insert is theoretically displayed on all five pIII molecules on a virion (though in practice normal proteolytic enzymes in the host bacterium often remove the foreign peptide from some or even most copies of pIII, especially if the foreign peptide is large). Similarly, type 8 . In a type 88 vector, the phage genome bears two genes VIII, encoding two different types of pVIII molecule; one is ordinarily recombinant (i.e., bears a foreign DNA insert) and the other wild-type. The resulting virion is a mosaic, its coat comprised of both wild-type and recombinant pVIII molecules (the former usually predominating). This allows hybrid pVIII proteins with quite large foreign peptides to be displayed on the virion surface, even though the hybrid protein by itself cannot support phage assembly. Similarly, a type 33 vector bears two genes III, one of which is recombinant.
  • 31.  A type 8+8 system differs from a type 88 system in that the two genes VIII are on separate genomes. The wild-type version is on a phage (usually called the “helper” phage), while the recombinant version is on a special kind of plasmid called a “phagemid. Like other plasmids used in recombinant DNA research, a phagemid carries a plasmid replication origin that allows it to replicate normally in an E. coli host and an antibiotic resistance gene that allows plasmid-bearing host cells to be selected. But it also carries a filamentous phage replication origin, which is inactive until the cell is infected with the helper phage. Then the phage replication protein acts not only on the phage origin on the helper phage DNA but also on the phage origin on the phagemid DNA. Two types of progeny virions are thus secreted: particles carrying helper phage DNA and particles carrying phagemid DNA. Both these virions, like the type 88 virions, are mosaics, whose coats are composed of a mixture of recombinant and wild-type pVIII molecules. When a phagemid virion infects a cell, the cell acquires the antibiotic resistance carried by the phagemid. When a helper phage virion infects a cell, the cell goes on to produce progeny helper virions in the normal way; the progeny virions, unlike the original infecting virion, are not mosaic, since the helper carries only a single gene VIII. Type 3+3 and 6+6 systems are like type 8+8 systems, except that the phagemid carries an insert-bearing recombinant gene III or VI, respectively, rather than VIII. The recombinant pIII encoded by a type 3+3 phagemid is usually missing the N-terminal domain, since cells expressing this domain are resistant to superinfection by helper phage.
  • 38.  Fab  F(ab)2  Fv  ScFv  HcAb
  • 47.  Library A population of clones with each clone containing one random piece of chromsomal DNA cloned into a vector.
  • 49.  Production of gene fragment: This phase involves animal immunization with the desired antigen and then isolation of B lymphocytes, mRNA extraction and cDNA synthesis. The synthesized cDNA contain genetic information of all antibodies targeting various antigens and consist of approximately10 ^9to10^ 11 lymphocyte clones.Cloning of gene fragments in the phagemid vectors: Genes related to the different clones of antibodies are digested with restriction enzymes, clone into phagemid vectors and then display on the surface of phages.
  • 50.  So far, a variety of phages like phages l, T4, T7and M13 have been described for displaying of antibody fragments. These vectors help to the displayed antibodies to maintain their function at the surface of phage. But using of phages like M13 that not destroy the bacterial cells is most applicable.The phagemid vectors need helper phage to package and exit from the bacterial cells and enter to the medium.
  • 51.  Selection of specific phages: After cloning of the fragments into phagemid vectors, because of diversity in antibody gene,variety of clones of antibodies display on the surface of the phage. Selections of specific clone that recognize the antigen(target of interest) perform by biopanning. Since the antibody fragments on the surface of the phage are functional so the phage carrying specific antibody can be isolated from non-specific phages (due to antigen–antibody binding properties).
  • 52.  The panning process include: immobilization of antigen, binding of the phages, washing and removing non- bonded phages, elution of the bonded phages, re-infection of the bacterial cells to amplify the eluted phages, purification of the recombinant phages and re-expression of antibodies on the surface of phage. Biopanning usually repeat 3 to 5 times to isolate specific antibodies with high affinity to target.
  • 53.  Screening: Isolation of antibodies with high affinity to target is the main aim of this step. Screening is performed using different methods like: immunoassay, immunocytochemistry,active isolation of cells due to their fluorescent properties and immunoblotting. In immunoassay, at first antigen is coated on solid phase, phage displaying antibody is added and then secondary antibody that detect the surface proteins of phages is added. After incubation and washing the signal value and binding is measured in appropriate wave length.
  • 77.  Production of mAbs by phage display: Hybridoma and phage display technology are common techniques to obtain monoclonal antibodies.Combination of B cell producing monoclonal antibody with mouse myeloma cells is the basis of hybridoma technology.  Despite of advantage of hybridoma technology there are some limitation: poor immunogenicity of some targets, high production cost,, time-consuming and need to myeloma cells.
  • 78.  Phage display has been used in enzymology to determine the substrate specificity and to develop modulators of both the active and allostericsitesoftheenzyme(Diamond,2007;KehoeandKay,2005 ;Kayetal.,2001;Benhar,2001).Themethodcanbeusedtodisplaym utantsof 854J. Pande et al. / Biotechnology Advances 28 (2010) 849–858 enzymes to study their mechanisms of action (Vanwetswinkel et al.,2000; Ponsard et al., 2001; Verhaert et al., 2002). Since filamentous phage is resistant to broad range of proteases, it has been used in identification of substrates of various proteases (Matthews and Wells,1993;Diamond,2007).
  • 79.  Phage display is a powerful technique in isolation of monoclonal antibodies with high affinity to their target.  Epitope mapping and finding mimotopes  Another application of phage display is to map epitope or binding site of antigen that is involved in interaction with anti body .Peptide phage display libraries described in above are useful tools for identification of continuous or linear epitopes involve in interaction with antibody. Isolation and identification of mimotopes from peptide phage libraries is powerful approach to improve immunological studies in order to design and develop vaccine candidate.Through peptide phage library and biopanning process, phages carrying peptides mimic the epitopes of the antigen are identified. Length of epitopes that are recognized by antibodies is between four to six amino acids. So, heptapeptide libraries are appropriate for identification of all linear epitopes.
  • 80.  Phage display has been used to identify agonists and antagonists to probe the receptor structure and function. The peptide libraries can be screened for binding to functionally folded extracellular domains of receptors that contain the site for natural ligand. Selected peptides that recognize the binding interface of the receptor can antagonize its interaction with the natural ligand. The structural and functiona properties of individual members of a large receptor family that bind the same natural ligands can be characterized with affinity selected peptides specific for each member (Koolpe et al., 2005). Phage encoded peptide ligands have also been selected for targets like G-protein coupled receptors, in which it is difficult to purify the functionallyfoldedextracellular receptor domains. Antibodiesspecific for the known receptor ligand can be used as a target to affinity select mimotopes of the ligand from phage display library. The selected mimotopes can be used to study the mechanism of interaction of ligand with its receptor and allow the development of potent agonist and antagonists (Bonetto et al., 2005). Receptor antagonists can also be obtainedby selecting peptides thatbindtothereceptoragonistand thereby inhibit its interaction with the receptor. An example is the invention of antagonistic peptide binding insulin-like growth factor-1(IGF-1) (Deshayes et al., 2002)